Start with a trustworthy OT asset inventory and zone model. You cannot enforce least privilege or prove compliance until you know which devices, embedded components, and communication paths exist in each production area. In regulated manufacturing, discovery comes before segmentation because the control boundary has to match operational reality.
Why inventory and zone mapping come first in pharmaceutical OT
The first step is not hardening a firewall rule or drafting a policy, it is establishing a trustworthy view of what is actually in the OT environment and how production areas are divided. In pharmaceutical manufacturing, FDA-aligned security work has to start with the asset base, embedded components, and the communication paths that support validated operations.
An OT Security Guide is useful here because the security boundary only makes sense when it reflects real process dependencies, not an assumed network diagram.
What the first step needs to establish
A useful inventory is more than a device list. It should identify controllers, HMIs, engineering workstations, network segments, vendor maintenance paths, sensors, firmware-dependent equipment, and the links between production lines and supporting systems. That is what lets teams separate safety-critical and quality-critical assets from lower-risk support components.
The zone model should then show where trust changes, where traffic is permitted, and where one compromised node could affect multiple production stages. For regulated environments, this is the basis for segmentation, remote access decisions, and later enforcement of least privilege.
This is also where a trusted ICS resource set from CISA helps teams translate plant reality into a defensible operational security model.
Why discovery before segmentation changes the security outcome
If teams segment before they understand the environment, they often create brittle controls that break batch operations, maintenance windows, or validated data flows. In pharmaceutical OT, that is not just an availability issue, it can also create compliance drift if the implemented boundary does not match how the process is actually run.
Discovery first makes the later decisions auditable. It lets security, engineering, quality, and operations agree on what belongs in each zone, which assets need continuous monitoring, and which interfaces should be restricted, brokered, or retired.
For teams building a broader control baseline after inventory, NIST SP 800-53 Rev. 5 is a practical follow-on reference for mapping those findings into access, configuration, audit, and integrity controls.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-53 Rev 5, NIST CSF 2.0 and CIS Controls v8 set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-53 Rev 5 | CM-8 — System Component Inventory | Inventorying OT assets is the first step in defining a trustworthy security boundary. |
| SC-7 — Boundary Protection | Zone models drive the boundaries that separate production areas and control flows. | |
| AC-6 — Least Privilege | The answer explains that least privilege cannot be enforced until assets and paths are known. | |
| Recommendation — Maintain an accurate component inventory before applying segmentation or access controls. Define and enforce boundaries around validated OT zones and conduits. Limit access by zone and function after the OT inventory is validated. | ||
| NIST CSF 2.0 | ID.AM-01 — Assets are inventoried | The question asks for the first step, which is trustworthy asset discovery. |
| PR.AA-05 — Access Permissions are Managed | Zone-aware inventory enables later permission and boundary enforcement. | |
| Recommendation — Inventory OT assets and communication paths before designing controls. Align permissions to validated OT zones and production roles. | ||
| CIS Controls v8 | CIS-1 — Inventory and Control of Enterprise Assets | Asset discovery is the starting point for managing OT exposure and control scope. |
| Recommendation — Build and maintain a complete OT asset inventory before segmentation. | ||
| ISO/IEC 27001:2022 | A.5.9 — Inventory of information and other associated assets | The question centers on establishing a trustworthy inventory as the foundation for control. |
| Recommendation — Document OT assets and ownership before implementing security zoning. | ||
Practitioner Guidance
What to verify: Confirm the inventory captures both active devices and the hidden dependencies that keep production stable, including firmware, vendor support links, and one-way or scheduled data transfers. If the zone model cannot explain a critical production path, the model is not ready for control design.
Implementation sequence: Start with passive discovery where possible, validate findings with engineering and operations, then define zones around actual production function rather than physical location alone. After that, use the validated map to decide where segmentation, access restrictions, and monitoring should be enforced first.
Practitioner takeaway: In pharmaceutical OT, security work becomes credible only after the environment is accurately described; every downstream control is stronger when it is built on a verified asset and zone model instead of assumptions.